Back

Risk modification role of opportunistic screening of lipoprotein(a) at first acute coronary syndrome admission in patients under 65 years old

14 April 2023 (08:30 - 09:30)
Organised by:
Congress Presentation Part of: Moderated ePoster 13 Lipids, Other EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Mr Leopoldo Fernandez Ruz

Regional University Hospital Carlos Haya, Malaga (Spain)

8 More presentations in this session

Presentation thumbnail
History of acute myocardial infarction in patients with acute coronary syndrome: population characterization and impact on prognosis.
Doctor M. Carias (Evora, PT)
Abstract Slides
Presentation thumbnail
Effect of prior statin treatment on the achievement of <55 mg/dL LDL cholesterol threshold in acute coronary syndrome patients undergoing percutaneous coronary intervention.
Doctor E. Tafaj (Tirana, AL)
Abstract Slides
Presentation thumbnail
Improved adherence to guideline-recommended treatments in a specialist preventative pharmacology clinic compared to standard cardiology clinics after an acute coronary syndrome
Doctor M. Thomas (Birmingham, GB)
Abstract Slides
Presentation thumbnail
Can previous therapy with statin be considered a protective factor in acute coronary syndrome?
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides
Presentation thumbnail
The associations between tricarboxylic acid cycle metabolites, and risk of major adverse cardiovascular events in acute coronary syndrome
Doctor R. Sanchez Gimenez (Tarragona, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePoster 13

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources